Article
BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention.
Neurology - 30 May 2017
Boots Elizabeth A, Schultz Stephanie A, Clark Lindsay R, Racine Annie M, Darst Burcu F, Koscik Rebecca L, Carlsson Cynthia M, Gallagher Catherine L, Hogan Kirk J, Bendlin Barbara B, Asthana Sanjay, Sager Mark A, Hermann Bruce P, Christian Bradley T, Dubal Dena B, Engelman Corinne D, Johnson Sterling C, Okonkwo Ozioma C
Abstract excerpt
OBJECTIVE: To examine the influence of the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism on longitudinal cognitive trajectories in a large, cognitively healthy cohort enriched for Alzheimer disease (AD) risk and to understand whether β-amyloid (Aβ) burden plays a moderating role in this relationship. METHODS: One thousand twenty-three adults (baseline age 54.94 ± 6.41 years) enrolled in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
